Inova Labs

AUSTIN, Texas, December 1, 2011 - - New Technology enables COPD patients to experience true portability while maintaining appropriate oxygen concentration levels during both day and night Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) Market, announced today that it has received CE Mark approval to begin marketing the LifeChoice Portable Oxygen Concentrator System in Europe.

AUSTIN, Texas, November 8, 2011 - Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, announced today that it has secured a Series B round of equity financing for up to $17.5M from an investment syndicate led by Latterell Venture Partners, based in San Francisco, Calif.